Biofrontera Community

Key Takeaways FDA approval for expanded Ameluz use and restructuring agreements enhance margins, supporting future revenue growth through increased average sales size and reduced costs. Successful Phase III study and clinical trial expansion position Biofrontera for market share growth by broadening Ameluz treatment applications and potentially fast-tracking FDA approvals.